Research·arXiv cs.CL·2d ago

VeriDx framework exposes flawed clinical reasoning in medical LLMs

Medical LLM evaluation has focused on final diagnoses and isolated reasoning steps, missing a critical failure mode: reaching correct answers through flawed logic. VeriDx introduces a disease-centric verification framework that maps free-form diagnostic reasoning against structured clinical profiles, tracking whether each hypothesis satisfies its obligations (key evidence checked, alternatives ruled out, contradictions resolved, relevant tests considered). This shifts medical AI assessment from answer-correctness to reasoning-integrity, exposing gaps that surface-level metrics miss. For healthcare AI deployment, this represents a maturation in how we validate clinical reasoning systems before real-world use.

Modelwire context

Explainer

VeriDx doesn't just ask whether an LLM reached the right diagnosis; it audits whether the model satisfied the clinical obligations that justify that diagnosis (evidence gathered, alternatives considered, contradictions resolved). This is a shift from outcome validation to process validation, and it exposes a failure mode that accuracy metrics alone cannot detect.

This connects directly to the radiology report work from last week, which found that AI models can match radiologists on diagnostic accuracy yet still fail to earn clinician trust due to stylistic misalignment. VeriDx addresses a deeper trust problem: even when the final answer is correct, clinicians need confidence that the reasoning path is sound. The framework also parallels E2A-Bench's evidence-to-action pipeline tracing, which measures whether financial VLMs maintain evidence traceability through their decision chain. Both papers recognize that high-stakes AI deployment requires auditing the full reasoning chain, not just the endpoint.

If VeriDx's disease-centric framework is adopted in regulatory submissions for medical LLM clearance (FDA 510(k) or equivalent) within the next 18 months, it signals the field has moved beyond accuracy benchmarks to reasoning integrity as a deployment requirement. If it remains confined to academic evaluation, the gap between research validation and clinical practice standards persists.

Coverage we drew on

E2A-Bench: Benchmarking Evidence-to-Action Reliability in Financial Chart Reasoning · arXiv cs.CL

This analysis is generated by Modelwire’s editorial layer from our archive and the summary above. It is not a substitute for the original reporting. How we write it.

MentionsVeriDx

Read full story at arXiv cs.CL →(arxiv.org)

Modelwire Editorial

This synthesis and analysis was prepared by the Modelwire editorial team. We use advanced language models to read, ground, and connect the day’s most significant AI developments, providing original strategic context that helps practitioners and leaders stay ahead of the frontier.

Our mission How we write

Modelwire summarizes, we don’t republish. arXiv cs.CL originally reported this story as “VeriDx: Earning the Right to Diagnose with Disease-Centric Verification”. The full content lives on arxiv.org. If you’re a publisher and want a different summarization policy for your work, see our takedown page.